On the effects of glucagon-like peptide-1 on blood glucose regulation in normal and diabetic subjects.
Holst
J J
JJ
Department of Medical Physiology, Panum Institute, University of Copenhagen, Denmark. holst@mfi.ku.dk
Toft-Nielsen
M B
MB
Orskov
C
C
Nauck
M
M
Willms
B
B
D000818:Animals; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000097:blood* / Q000188:drug therapy; D003922:Diabetes Mellitus, Type 1 / Q000097:blood; D004064:Digestive System / Q000187:drug effects; D004068:Digestive System Physiological Phenomena; D005934:Glucagon / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D052216:Glucagon-Like Peptide 1; D006706:Homeostasis; D006801:Humans; D007515:Islets of Langerhans / Q000378:metabolism; D010446:Peptide Fragments / Q000494:pharmacology* / Q000627:therapeutic use; D052336:Proglucagon; D011498:Protein Precursors / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D011499:Protein Processing, Post-Translational; D012016:Reference Values
D001786:Blood Glucose; D010446:Peptide Fragments; D011498:Protein Precursors; D052336:Proglucagon; D052216:Glucagon-Like Peptide 1; D005934:Glucagon